Last updated 2026-06-18
- Raised $1.2M crowdfunding round led by ExitValley, Jan 2026
- Raised $1.2M equity_crowdfunding, Sep 2020
- Raised $2M a_round, May 2016
Total raised
$4.4M
Last: crowdfunding 2026-01
Stage
Series A
Founded
2014
Headcount
3
HQ
Israel
Sector
Health Tech & Life Sciences
About
Concenter BioPharma develops drugs for treating and preventing type 2 diabetes. The company has developed a family of nonsteroidal chemical complexes made from components approved for clinical use. These new chemical entities constitute a protected platform of drugs with proven efficacy and safety. The members of the platform act as potent anti-inflammatory agents, strong iron-chelating agents, and antibiotic agents. These modes of action jointly assist in treating the causes and/or symptoms of multiple indications. Concenter BioPharma is a subsidiary of Silkim Pharma.
Funding history · 3 rounds · $4.4M total
2016-05
a_round
$2.0M
2020-09
equity_crowdfunding
$1.2M
2026-01
crowdfunding
$1.2M
Q&A
- What is Concenter BioPharma's primary focus?
- Concenter BioPharma develops drugs for the treatment and prevention of Type 2 Diabetes.
- How many employees does Concenter BioPharma have?
- Concenter BioPharma has 1-10 employees.
- When was Concenter BioPharma founded?
- Concenter BioPharma was founded in January 2014.
- What is the total amount of funding Concenter BioPharma has raised to date?
- Concenter BioPharma has raised a total of $4,373,000 USD.
- When was Concenter BioPharma's most recent funding round and who were the lead investors?
- Concenter BioPharma's most recent funding round was a crowdfunding round in January 2026, with ExitValley as a lead investor.
- Who are the co-founders of Concenter BioPharma?
- The co-founders of Concenter BioPharma are Dror Chevion (Co-founder & CEO) and Prof. Mordechai (Mottie) Chevion (Co-founder & CSO).
- What is Concenter BioPharma's current product stage?
- Concenter BioPharma's product is currently in the clinical trial stage.
- What is the primary sector of Concenter BioPharma?
- Concenter BioPharma's primary sector is Health Tech & Life Sciences.
Team · 2
Founder · Co-founder & CSO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
biopharmaceuticalbiotechnologyinflammatory-diseasespharma-companiesoral-drugsdrug-discoverydiabetespharmaceuticalsdrug-developmenttype-2-diabetes
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | concenterbiopharma.com |
|---|---|
| linkedin.com/company/9496898 | |
| facebook.com/concenterbiopharma |
Identifiers & details
| Founded | 2014-1 |
|---|---|
| Employees (exact) | 3 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | concenterbiopharma.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|